GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: CSII
Buy $41

Cardiovascular Systems Inc. (NASDAQ: CSII) reiterated to Buy with price target $41 by Wunderlich

Friday,  Jan 10, 2014  8:25 AM ET by Betsy O'Brien Harrison

Wunderlich reiterated Cardiovascular Systems Inc. (NASDAQ: CSII) to Buy with price target
$41. Previously Wunderlich reiterated Cardiovascular Systems Inc. (NASDAQ: CSII) to Buy with price target $34 on 10/31/2013, when the stock price was $29.85.

Cardiovascular Systems, Inc.(CSI) is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. The Company?s primary product, the Diamondback 360 PAD System, is a catheter-based platform capable of treating a range of plaque types in leg arteries both above and below the knee. In August 2007, the United States Food and Drug Administration (FDA) granted the Company 510(k) clearance for use of the Diamondback 360 as a therapy for treatment of patients with peripheral artery disease (PAD). As of June 30, 2009, it was selling the Diamondback 360 in 556 accounts that had completed an estimated 15,000 procedures. On February 25, 2009, Replidyne, Inc. completed its merger with Cardiovascular Systems, Inc. Pursuant to the merger, Replidyne merged with and into Cardiovascular Systems, Inc., with Cardiovascular Systems, Inc. continuing after the merger as the surviving company and a wholly owned subsidiary of Replidyne.

Advising private clients is a long-term and relationship-guided process. The Financial Advisors at Wunderlich Securities recognize that serving individuals and families requires an understanding of their individual goals and needs. Our approach involves a cycle of service. Wunderlich's Financial Advisors work with each client to design, implement and monitor a plan that serves the client's needs. We utilize a variety of high-quality investments including stocks, bonds, mutual funds, options and annuities to build diversified and balanced portfolios.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy